Shopping Cart
Remove All
Your shopping cart is currently empty
KH-259 (compound 1) is a highly potent, selective, and CNS-penetrant HDAC6 inhibitor, with an IC50 of 0.26 μM, exerting antidepressant effects in mice by inhibiting HDAC6 within the brain and holding promise as a valuable tool for neurodegenerative diseases research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $1,980 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $2,500 | 10-14 weeks | 10-14 weeks |
| Description | KH-259 (compound 1) is a highly potent, selective, and CNS-penetrant HDAC6 inhibitor, with an IC50 of 0.26 μM, exerting antidepressant effects in mice by inhibiting HDAC6 within the brain and holding promise as a valuable tool for neurodegenerative diseases research [1]. |
| Targets&IC50 | HDAC4:12.3 ± 0.4 μM, HDAC1:6.7 ± 0.14 μM, HDAC6:0.26 ± 0.2 μM |
| In vitro | KH-259 (compound 1) shows satisfactory metabolic stability in liver microsomes of both mice and humans [1]. |
| In vivo | Administration of KH-259 (compound 1) (10 mg/kg, IP, once) significantly raises acetylated α-tubulin levels in mice brains without affecting acetylated histone H3K9 levels, suggesting its antidepressant effects are mediated through inhibiting HDAC6 in the brain [1]. |
| Molecular Weight | 339.43 |
| Formula | C20H25N3O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.